| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc. | President and CEO, Director | Common Stock | 61,750 | $89,537 | $1.45 | 23 Feb 2026 | Direct |
| Ovid Therapeutics Inc. | President and CEO, Director | Employee Stock Option (Right to Buy) | 1,435,000 | 26 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | 23 Feb 2026 | 2 | -$16,901 | 4 | President and CEO, Director | 02 Mar 2026, 16:30 |
| OVID | Ovid Therapeutics Inc. | 04 Jan 2026 | 1 | $0 | 4 | President and CEO, Director | 05 Jan 2026, 17:55 |
| OVID | Ovid Therapeutics Inc. | 26 Feb 2025 | 1 | -$2,956 | 4 | President and COO | 28 Feb 2025, 16:15 |
| OVID | Ovid Therapeutics Inc. | 20 Feb 2025 | 2 | $0 | 4 | President and COO | 24 Feb 2025, 19:55 |
| OVID | Ovid Therapeutics Inc. | 27 Jan 2025 | 1 | +$4,971 | 4 | President and COO | 29 Jan 2025, 09:18 |
| OVID | Ovid Therapeutics Inc. | 09 Sep 2024 | 1 | $0 | 4 | President and COO | 11 Sep 2024, 17:38 |
| OVID | Ovid Therapeutics Inc. | 09 Sep 2024 | 0 | $0 | 3 | President and COO | 11 Sep 2024, 17:36 |